- $12.89m
- $12.05m
- $4.09m
- 10
- 28
- 29
- 11
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.717 | 0.674 | 1.55 | 2.05 | 4.09 |
Cost of Revenue | |||||
Gross Profit | -0.137 | -0.291 | 0.009 | 0.256 | 0.619 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2.64 | 2.93 | 3.87 | 5.55 | 7.57 |
Operating Profit | -1.92 | -2.26 | -2.32 | -3.5 | -3.48 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.92 | -2.26 | -4.31 | -4.75 | -3.19 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.92 | -2.26 | -4.31 | -4.75 | -3.19 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -1.92 | -2.26 | -4.31 | -4.75 | -3.16 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.92 | -2.26 | -4.31 | -4.75 | -3.16 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.346 | -0.407 | -0.818 | -0.824 | -0.557 |